On June 16, 2025, RemeGen Co., Ltd. ('RemeGen', stock symbols: 688331.SH/09995.HK) announced that telitacicept (RC18; brand ...

Myasthenia gravis is an autoimmune disease caused by neuromuscular junction transmission disorders. It is characterized by fluctuating muscle weakness and fatigue in symptoms, long treatment ...

Myasthenia Gravis Epidemiology Forecast – 2034 report delivers an in-depth understanding of the disease, historical and forecasted myasthenia gravis epidemiology in the 7MM, i.e., the United ...

The condition is caused by autoantibodies that target the neuromuscular junction—most often the acetylcholine receptor (AChR)—interfering with nerve signal transmission. MG affects up to 350 ...

YANTAI, China, April 8, 2025 /PRNewswire/ -- On April 8, 2025 (UTC-7), impressive results of the Phase 3 clinical trial (NCT05737160) evaluating the efficacy and safety of Telitacicept (synonym ...

This novel treatment approach has resulted in clinical evidence of CIC-1 inhibition in myasthenia gravis (MG) and preclinical evidence in spinal muscular atrophy, Charcot-Marie Tooth (CMT) disease and ...

As you can see, myasthenia gravis and LEMS are 2 distinct problems of the neuromuscular end plate. However, both exhibit similar symptoms with different behaviors of the muscle contraction.

Myasthenia gravis (MG) results from autoimmune antibodies against the post-synaptic neuromuscular junction with three major antibody categories: those to the acetylcholine receptor (AChR ...

Myasthenia gravis is a neuromuscular junction disorder with a hallmark of progressive muscle weakness and frequent manifestation of otolaryngologic dysfunction, such as difficulty swallowing and ...

Generalized myasthenia gravis (gMG) affects most patients through a handful of well-characterized neuromuscular junction autoantibodies, but a wide range of differences among patients affect the ...

About generalized myasthenia gravis (gMG) gMG is a rare autoimmune neuromuscular junction disease with a global prevalence of 100–350 cases per 1 million people. 5 People living with gMG can ...

Myasthenia gravis is a chronic condition that causes your muscles to weaken quickly. ... When you have myasthenia gravis, your immune system attacks the neuromuscular junction.